Multi-cancer blood test missed key goal in NHS trial
The company behind the test said there were positive signs that some of the most aggressive cancers could be prevented.
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
The company behind the test said there were positive signs that some of the most aggressive cancers could be prevented.
Similar Stories
Related coverage based on topic and tags
Advanced radiotherapy for prostate cancer to cut sessions from 20 to five
Some men in England with the disease will now be offered an advanced form of treatment on the NHS.
June 9, 2026 at 11:57 PMFocus: Cancer vaccines based on mRNA advance, despite US cuts - Reuters
Focus: Cancer vaccines based on mRNA advance, despite US cuts Reuters
June 9, 2026 at 07:01 PM'I've never been this good' – revolutionary immune reset puts lupus in remission
Patients on the trial have not needed medication to manage their condition.
June 11, 2026 at 11:31 PM'World-first' vaccine designed by artificial intelligence
Cambridge scientists say they have, for the first time, tested a vaccine designed by AI.
June 4, 2026 at 11:29 PMAI is boosting accuracy for clinicians, Philips North America CEO says - Reuters
AI is boosting accuracy for clinicians, Philips North America CEO says Reuters
June 9, 2026 at 07:02 PMWhat are the symptoms of prostate cancer and what should you check for?
One in eight men in the UK will be diagnosed with prostate cancer in their lifetime.
June 10, 2026 at 08:26 AM